James Bligh - Dec 1, 2023 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ James Bligh
Stock symbol
CDT
Transactions as of
Dec 1, 2023
Transactions value $
$1,232,223
Form type
4
Date filed
12/5/2023, 05:20 PM
Previous filing
Sep 26, 2023
Next filing
Jun 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $1.23M +224K $5.51 224K Dec 1, 2023 Common Stock 224K $5.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
F2 The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023.